Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$50,587,855
+$11,091,974 QoQ
Shares Held
234,138
+8.7% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#69
of 1,037 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $5,015,687,266 across 13 Drug Manufacturers - General names. BIIB ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,536,227 | $1,429,019,361 | |
| 2 | LLY |
ELI LILLY & Co
|
1,001,608 | $1,201,358,780 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,938,774 | $497,624,704 | |
| 4 | JNJ |
Johnson & Johnson
|
1,657,928 | $421,063,972 | |
| 5 | ABBV |
AbbVie Inc.
|
1,521,377 | $382,839,306 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,581,691 | $331,747,292 | |
| 7 | AMGN |
Amgen Inc
|
821,365 | $297,432,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,327,511 | $249,351,182 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,587,855 | 234,138 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $39,495,881 | 215,436 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $43,237,221 | 245,680 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $27,582,172 | 196,903 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $20,550,291 | 163,630 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $20,880,826 | 152,593 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $27,291,326 | 178,468 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $77,420,470 | 399,404 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $100,341,431 | 432,842 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $123,024,029 | 570,533 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $116,040,748 | 448,432 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $169,766,926 | 660,546 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $157,153,167 | 551,705 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $113,689,802 | 408,912 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $106,727,737 | 385,410 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $92,540,064 | 346,592 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $70,982,131 | 348,054 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $73,081,779 | 347,017 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $58,459,386 | 243,662 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $85,740,310 | 302,980 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $90,469,961 | 261,270 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $80,914,889 | 289,240 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $63,350,424 | 258,721 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $71,007,089 | 250,307 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $41,956,120 | 156,816 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $53,420,762 | 168,850 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||